• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)

$500.00 – $3,990.00

Clear
SKU: KLI2123096 Categories: Healthcare Facilities & Settings, Healthcare Market Research, Insurance & Managed Care Pages: 185
  • Description
  • Table of Contents
  • Latest reports

Description

Current economic conditions dominate business strategies. While healthcare has fared better than other industries, it will not be immune from the effects of the current recession. But what aspects of healthcare will be impacted? How much of spending will be out of the consumer’s pocket? How will some novel trends (retail clinics, medical tourism) fit into this economy? It is commonly asserted that OTC and generic drugs sales will be boosted. Will this pan out? What will be the possible effects of various types of healthcare plans that might be implemented?

In Healthcare in a Recession,Kalorama Information has examined all of the key medical markets in the past and has witnessed change and in some sector’s profits due to economic conditions. Kalorama has consulted its experts in key areas and asked about the effect of the recession. This report takes a broad look at the healthcare market in a recession from the many areas of healthcare that have changed or will changed. Specifically the report address:

 

  • The State of the Pharmaceutical Industry
  • Outsourcing and Offshoring
  • Generic Drugs: A Coming Boom?
  • Over the Counter Drugs
  • Possible impact of Healthcare Legislation
  • Out of Pocket Healthcare Spending: Current and Future
  • The Retail Clinic Phenomenon
  • Availability of Health Insurance
  • Medical Tourism: Boom or Bust?
  • Influential Pharmacists

 

As part of its research, Kalorama has profiled and detailed the activities of several companies in the pharmaceutical, retail, healthcare financing and information technology fields that likely to play some role in the healthcare economy of 2009:

 

  • APFUSA
  • Atlantic Care
  • Aurora Quick Care
  • Capitol One Healthcare Finance
  • Care Credit
  • Cerner Corporation
  • Credit Medical
  • CSI Financial Services
  • E- Financing Solutions
  • GlaxoSmithKline
  • Hospira Inc.
  • Med Basics
  • McKesson Corporation
  • Medco Health Solutions, Inc.
  • Merck & Co. Inc
  • Med choice Financial
  • MedDirect
  • Minute Clinic
  • Novartis
  • My Healthy Access
  • Now Medical Centers
  • PFS
  • Quick Health
  • Rediclinic
  • Reliance Medical Finance
  • Solantic
  • Take Care Health Systems
  • Target Clinic Medical Associates
  • TEVA Pharmaceutical Industries, Ltd.
  • Wyeth (Pfizer)
  • Siemens Medical Solutions
  • Wal – Mart

 

Table of Contents

CHAPTER ONE: EXECUTIVE SUMMARY

  • Out of Pocket Spending
  • Healthcare Legislation
  • State of the Pharmaceutical Industry, 2009 • Meeting Investor Expectations • Erosion of Blockbuster Sales • Increased Generic Competition • Pricing Pressures • Pipeline Output Slowing Compared to ROI • Mergers &Aquisitions
  • Retail Clinics
  • OTC/Generic Drugs

CHAPTER TWO: INTRODUCTION

  • The U.S. Healthcare System Today
  • Overview THE NEED FOR ALTERNATIVES
  • High Cost of Care
  • Healthcare Reform

CHAPTER THREE: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2009

  • Types of Expenditures
  • Insurance Co-Payments
  • Direct Payments
  • Premiums and Plan Fees
  • Cash or Check
  • Credit Cards
  • Loans and Lines of Credit
  • Flexible Spending Accounts
  • Health Savings Accounts
  • Medical Financing
  • Elective Procedures
  • Non-Elective Procedures and Prescription Drugs Consumers Who Pay Out Of Pocket
  • The Uninsured and Underinsured
  • Medicaid Recipients
  • The Disabled
  • Senior Citizens
  • The Mentally Ill
  • The Obese
  • Persons with Chronic Conditions

CHAPTER FOUR: OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2009 – 2013

  • Out-of-pocket Expenditure Growth Drivers
  • Payment Methods
  • Consumers Who Pay Out-of-pocket

CHAPTER FIVE: OVER THE COUNTER DRUGS: IN POSITION

  • United States Market
  • OTC and Recession: Avoiding the Copay
  • Behind the Counter Drugs?

CHAPTER SIX: INFLUENTIAL PHARMACISTS

  • Markets – Pharmacists Impact
  • The Prescribing Pharmacist
  • Main Drivers For Increased Pharmacist Prescription Authority

CHAPTER SEVEN: MEDICAL TOURISM: BOOM OR BUST?

  • Motivations for Medical Tourism
  • Impact of Recession
  • True Medical Tourism vs. All Healthcare for Foreigners

CHAPTER EIGHT: STATE OF THE PHARMACEUTICAL MARKET: OFFSHORING AND OUTSOURCING

  • Meeting Investor Expectations
  • Erosion of Blockbuster Sales
  • Increased Generic Competition
  • Pricing Pressures
  • Pipeline Output Slowing Compared to ROI
  • M&A Offshoring Clinical Trials
  • Size and Growth of the Market
  • Outsourcing: No Longer Optional For Pharma
  • Strategic Outsourcing
  • Outsourcing Manufacturing Operations

CHAPTER NINE: GENERIC DRUGS: COMING BOOM?

  • Overview
  • Issues in Generics

CHAPTER TEN: RETAIL CLINICS

  • Retail Clinics Business
  • Competition with Primary Care Providers
  • Regulation

CHAPTER ELEVEN: IMPACT OF HEALTHCARE LEGISLATION

  • Overview
  • Change for Pharma
  • Focus on Cost – Cutting
  • Healthcare Reform

CHAPTER TWELVE: COMPANY PROFILES

  • APFUSA
  • Atlantic Care
  • Aurora Quick Care
  • Capitol One Healthcare Finance
  • Care Credit
  • Cerner Corporation
  • Products and Service
  • Key Competitors
  • Credit Medical
  • CSI Financial Services
  • E- Financing Solutions
  • GlaxoSmithKline
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • OTC Products
  • Financial Information
  • Hospira Inc.
  • Med Basics
  • McKesson Corporation
  • Company Overview
  • Products and Service
  • Medco Health Solutions, Inc.
  • Merck & Co. Inc
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • Financial Information
  • Med choice Financial
  • MedDirect
  • Minute Clinic
  • Novartis
  • History and Lines of Business
  • Strategic Alliances
  • Vaccine Products
  • My Healthy Access
  • Now Medical Centers
  • Pfs
  • Quick Health
  • Rediclinic
  • Reliance Medical Finance
  • Solantic
  • Take Care Health Systems
  • Target Clinic Medical Associates
  • TEVA Pharmaceutical Industries, Ltd.
  • Wyeth (Pfizer)
  • History and Lines of Business
  • Vaccine Products
  • OTC Products
  • Financial Information
  • Siemens Medical Solutions
  • Key Competitors
  • Growth Strategy
  • Locations
  • Wal – Mart

LIST OF EXHIBITS CHAPTER TWO: INTRODUCTION

  • Figure 2-1:National Health Expenditures (NHE) and NHE as a Percent of GDP, 1980 – 2013
  • Figure 2-2: Unnecessary Deaths Resulting From Variations in Health Care Quality, by Condition (Prenatal Care, Diabetes Care, Beta Blocker Treatment, Breast Cancer Screening, Cholesterol Management, High Blood Pressure, Diabetes)
  • Figure 2-3:HEDIS Scores by Quality of Health Care Plan, 2008
  • Table 2-1: U.S. Health Care Coverage by State, 2008

CHAPTER THREE: OUT-OF-POCKET EXPENDITURES THE MARKET IN 2009

  • Figure 3-1:Premium Increases vs. Increases in Workers Earnings and Prices, 1989 – 2008
  • Figure 3-2: Consumer Out-of-pocket Health Care Expenditures,
  • Figure 3-3:Consumer Out-of-pocket Health Care Expenditures by Payment Type,2008
  • Table 3-1: Credit Card Debt of Consumers With Medical Debt, 2007
  • Table 3-2: Credit Card Debt of Consumers With Medical Debt, 2007
  • Table 3-3: Main Business Activities of Selected Medical Financing Companies,
  • Figure 3-4:by Percentile of Total Health Spending,
  • Figure 3-5:Methods of Financing Elective Procedures,
  • Figure 3-6: Average Share Paid Out-of-pocket by U.S. Residents with Health Care Spending by Type of Service, 2008
  • Figure 3-7: by Percentile of Total Health Spending and Type of Service, 2008
  • Figure 3-8: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2008
  • Figure 3-9: Distribution of Out-of-pocket Spending for the Average Person, by Spending Level, 2008
  • Figure 3-10: Drug Cost Coverage by Payor Type (Public, Private, Cash) 1965, 1986, 2000, 2004, 2008
  • Table 3-4: Obesity in the United States, 1980 – 2013
  • Figure 3-11: Proportion of Adults Under Age 65 With Chronic Conditions, 2008

CHAPTER FOUR: FORECASTED OUT-OF-POCKET EXPENDITURES: THE MARKET IN 2009 – 2013

  • Table 4-1: Selected Rx-to-OTC Switches in the United States, 1990 – Present
  • Table 4-2: Rx-to-OTC Switch Candidates in the United States, 2009 – 2013
  • Table 4-3: Consumer Out-of-pocket Expenditures per Worker 2003-2013 (in $)
  • Table 4-4: Consumer Out-of-pocket Expenditures by Type, 2003-2013
  • Figure 4-1: Proportion of Consumer Out-of-pocket Spending by Type of Health Care Expenditure
  • Table 4-5: Consumer Out-of-pocket Expenditures by Type, 2001-2011
  • Figure 4-2: Proportion of Consumer Out-of-pocket Spending by Payment Type, 2003, 2008, 2013
  • Table 4-6: Amount of Consumer Out-of-pocket Expenditures for Elective Procedures That Are Financed, 2003-2013
  • Table 4-7: Amount of Consumer Out-of-pocket Expenditures for Non-Elective Procedures That Are Financed, 2001-2011
  • Figure 4-3: Proportion of Consumer Out-of-pocket Spending for Elective ProceduresThat is Financed (All Methods),
  • Figure 4-4: Distribution of Out-of-pocket Spending on Non-Elective Procedures for the Average Person, 2008, 2013
  • Figure 4-5: Proportion of Consumer Out-of-pocket Spending for Non-Elective Procedures That is Financed (All Methods),2008 – 2013
  • Table 4-8: Size of High Risk Groups for High Out-of-pocket Health Care Expenditures, 2003-2013 (Millions of Persons)

CHAPTER FIVE: OVER THE COUNTER DRUGS: IN POSITION

  • Table 5-1: Projected US OTC Revenues 2008-2012

CHAPTER SIX: INFLUENTIAL PHARMACISTS

  • Figure 6-1: Declining Drug Purchases Not Influenced By Pharmacists, 2006-2012
  • Table 6-1: Pharmacists Influence in Drug Selection and/or Therapy Aspect: 2007 and 2012
  • Table 6-2: States Likely to Implement Independent Prescribing First

CHAPTER SEVEN: MEDICAL TOURISM: BOOM OR BUST?

  • Table 7-1: Cost Savings From Medical Tourism For Various Procedures, 2008
  • Figure 7-1: US ‘True Medical Tourism’ Revenues, 2008, 2010

CHAPTER EIGHT: STATE OF THE PHARMACEUTICAL MARKET,: OFFSHORING AND OUTSOURCING

  • Table 8-1: Clinical Trial Market in Select Countries 2006-2012
  • Table 8-2: Global Prescription Pharmaceutical Contract Manufacturing Market Primary, Secondary and Biomanufacturing 2003-2013

CHAPTER NINE: GENERIC DRUGS: COMING BOOM?

  • Table 9-1: US Generic Drug Market 2008-2012

CHAPTER TEN: RETAIL CLINICS

  • Figure 10-1: Growth of U.S. Retail Clinic Services

CHAPTER ELEVEN: IMPACT OF HEALTHCARE LEGISLATION

  • Table 11-1: Likely Impact of Events and Proposed Legislation (Propsed Change, Probability, Positive Impact, Negative Impact)

CHAPTER TWELVE: COMPANY PROFILES

    Clinical Diagnostics MasterFile
    August 30, 2021
    The U.S. Market for Urgent Care Centers (Including COVID-19, POC Tests, Vaccines and Other Sales)
    September 18, 2020
    The Market for Urgent Care Centers
    August 6, 2019
    Retail Clinics 2019 Forecast: Locations, Revenues, Supplier Sales, Trends, Consumer Survey
    November 15, 2018

Related products

  • Placeholder image

    Healthcare Computer System Markets and Trends in HIT Buying (Forecasts for System, Service and Support Revenues, Areas of interest, major competitor profiles)

    $1,995.00 – $7,000.00
  • Placeholder image

    Wellness Market Opportunities in the Aging American Population: Alternative Medicine Markets for Age-Related Health Issues

    $3,500.00 – $7,000.00
  • Placeholder image

    The Global Market for RFID in Healthcare

    $995.00 – $1,990.00
  • Placeholder image

    Growing “Out of Pocket” Healthcare Market (Spending on Surgeries, Pharmaceuticals and Other Healthcare Services), The

    $3,250.00 – $6,500.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Wound Care Markets, 4th. Edition, Vol. I: Skin UlcersWorld Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and...
Scroll to top